ロード中...
New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor)
Systemic lupus erythematosus (SLE) is a systemic autoimmune rheumatic disease of unknown etiology, characterized by overproduction of organ-specific autoantibodies to various components of the cell nucleus and the development of immune-inflammatory damage to internal organs. According to modern conc...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
IMA-PRESS LLC
2021-10-01
|
| シリーズ: | Научно-практическая ревматология |
| 主題: | |
| オンライン･アクセス: | https://rsp.mediar-press.net/rsp/article/view/3072 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|